The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)


Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) (via PR Newswire)

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the…



Article Archive

back